What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Hypovitaminosis D common in SLE
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Rheumatologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
41 Hepatitis B virus reactivation in a Juvenile Rheumatoid arthritis patient under treatment and its successful management: a complicated case Rheumatology International, April 23, 2013
42 Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure Clinical Rheumatology, April 22, 2013 Clinical Article
43 The Impact of Evidence-Based Clinical Practice Guidelines Applied by a Multidisciplinary Team for the Care of Children with Osteomyelitis The Journal of Bone & Joint Surgery, April 19, 2013 Clinical Guideline
44 Causes, mechanisms and management of paediatric osteoporosis Nature Reviews Rheumatology , April 19, 2013 Clinical Article
45 Race, Ethnicity, and Disease Outcomes in Juvenile Idiopathic Arthritis: A Cross-sectional Analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry The Journal of Rheumatology, April 18, 2013 Clinical Article
46 Juvenile Idiopathic Arthritis: Review of the Literature and Case Report Journal of Dentistry for Children, April 18, 2013 Review Article
47 Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009 The Journal of Rheumatology, April 17, 2013 Clinical Article
48 Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis Pediatric Rheumatology, April 16, 2013 Clinical Article
49 Etanercept Improves Lipid Profile and Oxidative Stress Measures in Patients with Juvenile Idiopathic Arthritis The Journal of Rheumatology, April 15, 2013 Clinical Article
50 The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis Annals of Rheumatic Diseases, April 15, 2013 Review Article
51 Evaluation of Static and Dynamic Postural Balance in Children With Juvenile Idiopathic Arthritis Pediatric Physical Therapy, April 12, 2013 Clinical Article
52 Pulmonary function tests in idiopathic inflammatory myopathy: Association with clinical parameters in children Arthritis Care & Research , April 10, 2013 Clinical Article
53 MRI guided wire localization muscle biopsy in a child with juvenile dermatomyositis Pediatric Rheumatology, April 9, 2013
54 Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register Annals of Rheumatic Diseases, April 8, 2013 Clinical Article
55 Changes in Pain Coping, Catastrophizing, and Coping Efficacy After Cognitive-Behavioral Therapy in Children and Adolescents With Juvenile Fibromyalgia The Journal of Pain, April 8, 2013 Clinical Article
56 Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India Rheumatology International, April 8, 2013 Clinical Article
57 Sexual maturation in Moroccan patients with juvenile idiopathic arthritis Rheumatology International, April 8, 2013 Review Article
58 Understanding why cognitivebehavioral therapy is an effective treatment for adolescents with juvenile fibromyalgia International Journal of Clinical Rheumatology, April 5, 2013 Clinical Article
59 Positive Association Between Perfluoroalkyl Chemicals and Hyperuricemia in Children American Journal of Epidemiology, April 5, 2013 Clinical Article
60 Necrosis of the tongue as first symptom of Polyarteritis Nodosa (PAN): unusual presentation of a rare disease in children Rheumatology International, April 4, 2013
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryIn a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryIn a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summary1 Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis Pediatric Rheumatology, April 16, 2013
2 Hypermobility is a risk factor for musculoskeletal pain in adolescence: Findings from a prospective cohort study Arthritis & Rheumatism, April 2, 2013
3 Role of methotrexate in juvenile idiopathic arthritis: where we have been and where we are going International Journal of Clinical Rheumatology, March 25, 2013 Review Article
4 Race, Ethnicity, and Disease Outcomes in Juvenile Idiopathic Arthritis: A Cross-sectional Analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry The Journal of Rheumatology, April 18, 2013
5 Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure Clinical Rheumatology, April 22, 2013
6 Chronic Non-bacterial Osteomyelitis in Childhood a Comprehensive Review Current Rheumatology Reviews, April 23, 2013 Review Article
7 The Impact of Evidence-Based Clinical Practice Guidelines Applied by a Multidisciplinary Team for the Care of Children with Osteomyelitis The Journal of Bone & Joint Surgery, April 19, 2013 Clinical Guideline
8 Chronic recurrent multifocal osteomyelitis (CRMO): a longitudinal case series review Pediatric Radiology, February 22, 2013 Review Article
9 Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India Rheumatology International, April 8, 2013
10 The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis Annals of Rheumatic Diseases, April 15, 2013 Review Article
11 Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis Pediatric Rheumatology, March 19, 2013 Review Article
12 Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009 The Journal of Rheumatology, April 17, 2013
13 Understanding why cognitivebehavioral therapy is an effective treatment for adolescents with juvenile fibromyalgia International Journal of Clinical Rheumatology, April 5, 2013
14 Out-of-clinic patient communication in paediatric rheumatology: the extent and nature of demand Pediatric Rheumatology, March 28, 2013 Review Article
15 Cardiovascular risk in juvenile idiopathic arthritis Rheumatology, March 18, 2013
16 Long-Term Bone Health in Glucocorticoid-Treated Children with Rheumatic Diseases Current Rheumatology Reports, February 4, 2013
17 Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritis Pediatric Rheumatology, April 3, 2013 Review Article
18 Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis International Journal of Clinical Rheumatology, April 2, 2013
19 Familial Mediterranean fever in heterozygotes: Are we able to accurately diagnose the disease in very young children Arthritis & Rheumatism, March 19, 2013 Clinical Guideline
20 MEFV gene mutations in Turkish children with juvenile idiopathic arthritis European Journal of Pediatrics, April 26, 2013 Review Article
Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close